{"id":64546,"date":"2020-12-31T23:00:30","date_gmt":"2020-12-31T15:00:30","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=154221"},"modified":"2020-12-31T23:00:30","modified_gmt":"2020-12-31T15:00:30","slug":"china-oks-1st-homegrown-vaccine-as-covid-19-surges-globally","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2020\/12\/31\/china-oks-1st-homegrown-vaccine-as-covid-19-surges-globally\/","title":{"rendered":"China OKs 1st homegrown vaccine as COVID-19 surges globally"},"content":{"rendered":"<p>\u2022 12 Responds Coverage &#38; Info \u00bb<\/p>\n<p>BEIJING (AP) \u2014 China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in poorer countries as the virus surges back around the globe.<\/p>\n<p>The Sinopharm vaccine had already been given to groups such as health care professionals and essential workers under emergency-use guidelines as part of China\u2019s program to inoculate 50 million people before the Lunar New Year holiday in February.&#8230;<\/p>\n<p>This news comes via <a href=\"https:\/\/www.chinapulse.com\/\"  title=\"Best source for Chinese news in English\">ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2022 12 Responds Coverage &#038; Info \u00bb<br \/>\nBEIJING (AP) \u2014 China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in poorer countries as the virus surges back around the globe.<br \/>\nThe Sinopharm &#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65,144,213,69,325,288,194,249,1542,296,121],"tags":[2211,10483,7582,2636,8493,3472,10324,3773,2214,10501,10328,1859,10400,5941,7035,2972],"class_list":["post-64546","post","type-post","status-publish","format-standard","hentry","category-beijing","category-china","category-china-news","category-copyright","category-education","category-medicine","category-news-chinese-law","category-russia","category-technology","category-world-health-organization","category-wuhan","tag-argentina","tag-belarus","tag-biotech","tag-brazil","tag-britain","tag-chinese","tag-covid-19","tag-distribution","tag-indonesia","tag-morocco","tag-pandemic","tag-singapore","tag-turkey","tag-united-arab-emirates","tag-vaccine","tag-xi-jinping"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=64546"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64546\/revisions"}],"predecessor-version":[{"id":64547,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64546\/revisions\/64547"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=64546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=64546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=64546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}